Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18235124 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: paclitaxel albumin-stabilized nanoparticle formulation

Indicates status has not been verified in more than two years